Glioblastoma Multiforme (GBM) Therapeutics Market Report

Global and Region Glioblastoma Multiforme (GBM) Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：141
  • REPORT CODE：GMM964407
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Glioblastoma Multiforme (GBM) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Glioblastoma Multiforme (GBM) Therapeuticsmarket, defines the market attractiveness level of Glioblastoma Multiforme (GBM) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Glioblastoma Multiforme (GBM) Therapeutics industry, describes the types of Glioblastoma Multiforme (GBM) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Glioblastoma Multiforme (GBM) Therapeutics market and the development prospects and opportunities of Glioblastoma Multiforme (GBM) Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Glioblastoma Multiforme (GBM) Therapeutics market in Chapter 13.

    By Player:

    • Amgen

    • AbbVie

    • Teva Pharmaceutical

    • Roche

    • Merck

    • Emcure Pharmaceuticals

    • Pfizer

    • Arbor Pharmaceuticals

    • Bristol-Myers Squibb

    • Sun Pharmaceuticals

    By Type:

    • Chemotherapy

    • Targeted Drug Therapy

    • Radiation Therapy

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Glioblastoma Multiforme (GBM) Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Glioblastoma Multiforme (GBM) Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Glioblastoma Multiforme (GBM) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Glioblastoma Multiforme (GBM) Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Glioblastoma Multiforme (GBM) Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Glioblastoma Multiforme (GBM) Therapeutics Consumption (2017-2022)

    • 7.2 United States Glioblastoma Multiforme (GBM) Therapeutics Consumption (2017-2022)

    • 7.3 Europe Glioblastoma Multiforme (GBM) Therapeutics Consumption (2017-2022)

    • 7.4 China Glioblastoma Multiforme (GBM) Therapeutics Consumption (2017-2022)

    • 7.5 Japan Glioblastoma Multiforme (GBM) Therapeutics Consumption (2017-2022)

    • 7.6 India Glioblastoma Multiforme (GBM) Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Glioblastoma Multiforme (GBM) Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Glioblastoma Multiforme (GBM) Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast (2022-2028)

    9 Global Glioblastoma Multiforme (GBM) Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Glioblastoma Multiforme (GBM) Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Targeted Drug Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Radiation Therapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Glioblastoma Multiforme (GBM) Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Glioblastoma Multiforme (GBM) Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Targeted Drug Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Glioblastoma Multiforme (GBM) Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Glioblastoma Multiforme (GBM) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Glioblastoma Multiforme (GBM) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Glioblastoma Multiforme (GBM) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Glioblastoma Multiforme (GBM) Therapeutics Market Competitive Analysis

    • 14.1 Amgen

      • 14.1.1 Amgen Company Details

      • 14.1.2 Amgen Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Amgen Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • 14.2 AbbVie

      • 14.2.1 AbbVie Company Details

      • 14.2.2 AbbVie Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 AbbVie Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • 14.3 Teva Pharmaceutical

      • 14.3.1 Teva Pharmaceutical Company Details

      • 14.3.2 Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • 14.4 Roche

      • 14.4.1 Roche Company Details

      • 14.4.2 Roche Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Roche Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • 14.5 Merck

      • 14.5.1 Merck Company Details

      • 14.5.2 Merck Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Merck Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • 14.6 Emcure Pharmaceuticals

      • 14.6.1 Emcure Pharmaceuticals Company Details

      • 14.6.2 Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • 14.7 Pfizer

      • 14.7.1 Pfizer Company Details

      • 14.7.2 Pfizer Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Pfizer Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • 14.8 Arbor Pharmaceuticals

      • 14.8.1 Arbor Pharmaceuticals Company Details

      • 14.8.2 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • 14.9 Bristol-Myers Squibb

      • 14.9.1 Bristol-Myers Squibb Company Details

      • 14.9.2 Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • 14.10 Sun Pharmaceuticals

      • 14.10.1 Sun Pharmaceuticals Company Details

      • 14.10.2 Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Glioblastoma Multiforme (GBM) Therapeutics

    • Figure Glioblastoma Multiforme (GBM) Therapeutics Picture

    • Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Glioblastoma Multiforme (GBM) Therapeutics Consumption by Country (2017-2022)

    • Figure United States Glioblastoma Multiforme (GBM) Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Glioblastoma Multiforme (GBM) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Glioblastoma Multiforme (GBM) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Glioblastoma Multiforme (GBM) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Glioblastoma Multiforme (GBM) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Glioblastoma Multiforme (GBM) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Glioblastoma Multiforme (GBM) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted Drug Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted Drug Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Glioblastoma Multiforme (GBM) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Glioblastoma Multiforme (GBM) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • Table Emcure Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • Table Arbor Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Product and Service

    • Table Sun Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US